✦ LIBER ✦
MELPHALAN-PREDNISONE-THALIDOMIDE (MP-T) DEMONSTRATES A SIGNIFICANT SURVIVAL ADVANTAGE IN ELDERLY PATIENTS >75 YEARS WITH MULTIPLE MYELOMA COMPARED WITH MELPHALAN-PREDNISONE (MP) IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, IFM01/01
✍ Scribed by C. Hulin; O. Decaux; V. Coiteux; P. Rodon; B. Pegourie; L. Benboubker; L. Gagneux; M. Dib; L. Voillat; G. Guillerm; P. Moreau
- Book ID
- 117645106
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 79 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0953-6205
No coin nor oath required. For personal study only.